UK’s NICE recommends talazoparib for treatment of advanced breast cancer
The decision from NICE marks a shift from its previous preliminary stance of not supporting the use of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Jan 24
The decision from NICE marks a shift from its previous preliminary stance of not supporting the use of…
25 Oct 23
The governing body has launched a European Voluntary Solidarity Mechanism, will create a union list of critical medicines,…
05 Oct 23
The new draft guidance reveals the US regulator’s current views on developing drugs and biologics for stimulant use…
10 Aug 23
Informally referred to as Eris, the new strain descends from the lineage of XBB.1.9.2, and would pose relatively…
18 May 23
The task force has already set up two working groups, which will focus on childhood/young adult cancer and…
27 Mar 23
The changes will support the development of a healthier food supply by offering the flexibility to replace salt…
01 Sep 22
Pfizer and BioNTech’s bivalent Covid-19 vaccine is authorised as single booster dose for adults and adolescents aged 12…
22 Jul 22
CMA concluded that the companies exploited their dominant market position to inflate the final price for the key…
21 Jul 22
Biogen was alleged of paying kickbacks to health care professionals to discourage them from prescribing products of its…
13 Jul 22
Teva will pay $24.8m and supply generic overdose-reversal medicine Narcan worth $20m, while AbbVie will pay $13m to…